Sometimes a study comes along that shows some amazing results and one published in The Lancet does just that.
The study - which looked at people aged between 30 and 85 who were overweight or had obesity - has found a "globally available, low-cost, and safe" diabetes drug called metformin could drastically reduce the instances of long COVID by 40 per cent.
Sadly they didn't find the same results with ivermectin (and they looked).
So what could be going on? How could this old drug be so good at what it's doing? And how could this drug be used to help bring down long COVID cases?
That's on this week's Coronacast - along with a clarification of NSW hospital data and antiviral prescriptions.
Or watch us on YouTube here
Learn more about your ad choices. Visit megaphone.fm/adchoices
Is melatonin the answer to a good night's sleep?
What it takes to avoid iron deficiency
Why do hangovers get worse as we age?
Rapid-fire round: Answering your sleep questions
Can you zap yourself buff with electrical muscle stimulation?
Why Norman won't shut up about the Mediterranean diet
Sweaty sauna bathing for better health
Can't stop biting your nails?
Is being an Olympian bad for your health?
Are office jobs ruining our bodies?
What does sneezing have to do with orgasms?
Norman tried an ice bath so you don't have to
How risky is sharing a toothbrush?
Is gluten really the enemy?
Phlegm — better out than in?
Is botox worth a shot?
Should we all be vegetarian?
Is apple cider vinegar a cure-all tonic?
Can you train yourself to sleep less?
Why everything hurts when you turn 30
Create your
podcast in
minutes
It is Free
Consider This from NPR
Chasing Life
The Coronavirus Podcast
Up First from NPR
The Daily